# BridgeBio Pharma, Inc. (BBIO) — Operating Income

## Annual Operating Income (USD)

| Year | Operating Income |
| --- | --- |
| 2025 | -$523M |
| 2024 | -$593M |
| 2023 | -$607M |
| 2022 | -$512M |
| 2021 | -$577M |
| 2020 | -$474M |
| 2019 | -$266M |

## Quarterly Operating Income (USD)

| Quarter | Operating Income |
| --- | --- |
| 2026-03-31 | -$106M |
| 2025-09-30 | -$145M |
| 2025-06-30 | -$134M |
| 2025-03-31 | -$104M |
| 2024-09-30 | -$192M |
| 2024-06-30 | -$176M |
| 2024-03-31 | $343,000 |
| 2023-09-30 | -$158M |
| 2023-06-30 | -$146M |
| 2023-03-31 | -$126M |
| 2022-09-30 | -$129M |
| 2022-06-30 | -$80M |
| 2022-03-31 | -$174M |
| 2021-09-30 | -$149M |
| 2021-06-30 | -$94M |
| 2021-03-31 | -$168M |
| 2020-09-30 | -$120M |
| 2019-09-30 | -$55M |

Source: [MarketCapTrends](https://marketcaptrends.com/company/BBIO/operating-income)